214 related articles for article (PubMed ID: 12782587)
21. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
Hurd C; Dinda S; Khattree N; Moudgil VK
Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
[TBL] [Abstract][Full Text] [Related]
22. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
24. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
Shatnawi A; Tran T; Ratnam M
Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
[TBL] [Abstract][Full Text] [Related]
25. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
Catherino WH; Wolf DM; Jordan VC
Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
[TBL] [Abstract][Full Text] [Related]
26. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
Zhang CC; Krieg S; Shapiro DJ
Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
[TBL] [Abstract][Full Text] [Related]
27. 17 beta-estradiol stimulates mouse neuropeptide Y-Y(1) receptor gene transcription by binding to estrogen receptor alpha in neuroblastoma cells.
Musso R; Maggi A; Eva C
Neuroendocrinology; 2000 Dec; 72(6):360-7. PubMed ID: 11146419
[TBL] [Abstract][Full Text] [Related]
28. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.
An J; Ribeiro RC; Webb P; Gustafsson JA; Kushner PJ; Baxter JD; Leitman DC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15161-6. PubMed ID: 10611355
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by antiestrogens.
Fournier B; Gutzwiller S; Dittmar T; Matthias G; Steenbergh P; Matthias P
J Biol Chem; 2001 Sep; 276(38):35444-9. PubMed ID: 11457856
[TBL] [Abstract][Full Text] [Related]
30. An activator protein 1-like motif mediates 17beta-estradiol repression of gonadotropin-releasing hormone receptor promoter via an estrogen receptor alpha-dependent mechanism in ovarian and breast cancer cells.
Cheng CK; Chow BK; Leung PC
Mol Endocrinol; 2003 Dec; 17(12):2613-29. PubMed ID: 12947046
[TBL] [Abstract][Full Text] [Related]
31. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.
Saville B; Wormke M; Wang F; Nguyen T; Enmark E; Kuiper G; Gustafsson JA; Safe S
J Biol Chem; 2000 Feb; 275(8):5379-87. PubMed ID: 10681512
[TBL] [Abstract][Full Text] [Related]
32. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.
Fan JD; Wagner BL; McDonnell DP
Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270
[TBL] [Abstract][Full Text] [Related]
33. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.
Tremblay GB; Tremblay A; Copeland NG; Gilbert DJ; Jenkins NA; Labrie F; Giguère V
Mol Endocrinol; 1997 Mar; 11(3):353-65. PubMed ID: 9058381
[TBL] [Abstract][Full Text] [Related]
34. Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: implications for their mechanism of action.
Dudley MW; Sheeler CQ; Wang H; Khan S
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3696-701. PubMed ID: 10725345
[TBL] [Abstract][Full Text] [Related]
35. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
[TBL] [Abstract][Full Text] [Related]
36. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
van den Wijngaard A; Mulder WR; Dijkema R; Boersma CJ; Mosselman S; van Zoelen EJ; Olijve W
Mol Endocrinol; 2000 May; 14(5):623-33. PubMed ID: 10809227
[TBL] [Abstract][Full Text] [Related]
37. Differential interaction of estrogen receptor and thyroid hormone receptor isoforms on the rat oxytocin receptor promoter leads to differences in transcriptional regulation.
Vasudevan N; Davidkova G; Zhu YS; Koibuchi N; Chin WW; Pfaff D
Neuroendocrinology; 2001 Nov; 74(5):309-24. PubMed ID: 11694763
[TBL] [Abstract][Full Text] [Related]
38. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects.
Scheidegger KJ; Cenni B; Picard D; Delafontaine P
J Biol Chem; 2000 Dec; 275(49):38921-8. PubMed ID: 10982795
[TBL] [Abstract][Full Text] [Related]
39. Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression.
Ni X; Nicholson RC; King BR; Chan EC; Read MA; Smith R
J Clin Endocrinol Metab; 2002 Aug; 87(8):3774-8. PubMed ID: 12161509
[TBL] [Abstract][Full Text] [Related]
40. Novel intronic promoter in the rat ER alpha gene responsible for the transient transcription of a variant receptor.
Tiffoche C; Vaillant C; Schausi D; Thieulant ML
Endocrinology; 2001 Sep; 142(9):4106-19. PubMed ID: 11517190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
